Current
$96.2B
5-Year Average
$81.3B
All-Time High
$118B
All-Time Low
$1.24B
Market cap daily chart for CME Group (CME)
Aug 2, 2021 – Jul 29, 2026 · 1,253 trading days
Market Cap growth chart for CME Group (CME) from 2017 to 2026
Latest: -2.3%
Market Cap history table for CME Group (CME) from 2002 to 2026
| 2026 | $96.2B | -2.3% | -$2.22B | ||
| 2025 | $98.4B | +17.7% | +$14.8B | ||
| 2024 | $83.6B | +10.4% | +$7.88B | ||
| 2023 | $75.7B | +25.3% | +$15.3B | ||
| 2022 | $60.4B | -26.3% | -$21.6B | ||
| 2021 | $82B | +25.6% | +$16.7B | ||
| 2020 | $65.3B | -9.2% | -$6.64B | ||
| 2019 | $71.9B | +11.2% | +$7.24B | ||
| 2018 | $64.7B | +30.1% | +$15B | ||
| 2017 | $49.7B | +27.1% | +$10.6B | ||
| 2016 | $39.1B | +27.7% | +$8.49B | ||
| 2015 | $30.6B | +2.8% | +$821M | ||
| 2014 | $29.8B | +13.6% | +$3.56B | ||
| 2013 | $26.2B | +55.8% | +$9.4B | ||
| 2012 | $16.8B | +3.5% | +$572M | ||
| 2011 | $16.3B | -24.0% | -$5.13B | ||
| 2010 | $21.4B | -4.3% | -$962M | ||
| 2009 | $22.4B | +82.2% | +$10.1B | ||
| 2008 | $12.3B | -59.4% | -$18B | ||
| 2007 | $30.3B | +69.0% | +$12.4B | ||
| 2006 | $17.9B | +39.8% | +$5.1B | ||
| 2005 | $12.8B | +62.7% | +$4.93B | ||
| 2004 | $7.87B | +220.5% | +$5.41B | ||
| 2003 | $2.46B | +87.1% | +$1.14B | ||
| 2002 | $1.31B | — | — |
- 2026$96.2B-2.3%
- 2025$98.4B+17.7%
- 2024$83.6B+10.4%
- 2023$75.7B+25.3%
- 2022$60.4B-26.3%
- 2021$82B+25.6%
- 2020$65.3B-9.2%
- 2019$71.9B+11.2%
- 2018$64.7B+30.1%
- 2017$49.7B+27.1%
- 2016$39.1B+27.7%
- 2015$30.6B+2.8%
- 2014$29.8B+13.6%
- 2013$26.2B+55.8%
- 2012$16.8B+3.5%
- 2011$16.3B-24.0%
- 2010$21.4B-4.3%
- 2009$22.4B+82.2%
- 2008$12.3B-59.4%
- 2007$30.3B+69.0%
- 2006$17.9B+39.8%
- 2005$12.8B+62.7%
- 2004$7.87B+220.5%
- 2003$2.46B+87.1%
- 2002$1.31B—
Market Cap values are taken from CME Group's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at CME Group (CME)
According to CME Group's latest reported financial statements, the company's latest reported market cap is $80B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
CME Group (CME) most recent annual market cap stands at $96.2B (2026) – edged down 2.3% year-over-year.
Looking at the 2021–2026 (5 years) stretch, CME Group market cap compounded at +3.2% per year, with mixed annual results across the window.
Between 2025 and 2026, CME Group market cap edged down 2.3%, falling from $98.4B to $96.2B.
2025 marks the peak market cap at $98.4B, with the historical low of $1.31B recorded in 2002.
CME Group Market Cap by Year
CME Group Market Cap 2026: $96.2B
In 2026, CME Group reported market cap of $96.2B, edged down 2.3% below 2025.
CME Group Market Cap 2025: $98.4B
CME Group market cap in 2025 was $98.4B, grew 17.7% from 2024. This figure represents the highest annual value in the available history.
CME Group Market Cap 2024: $83.6B
2024's market cap for CME Group came in at $83.6B, grew 10.4% from 2023.
CME Group Market Cap 2023: $75.7B
CME Group posted market cap of $75.7B in 2023, grew 25.3% from 2022.
CME Group Market Cap 2022: $60.4B
CME Group market cap in 2022 was $60.4B.
See more financial history for CME Group (CME).
Sector peers by Market Cap
Financial Services peers of CME Group (CME), ranked by their latest market cap
| $1.1T | |
| $924B | |
| $677B | |
| $498B | |
| $433B | |
| $320B | |
| $289B | |
| $257B |
- $924B
- $677B
- $498B
- $320B
- $289B
- $257B
Frequently asked questions
Test yourself on CME
Market Cap — 10 rounds, every one of them CME against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
CME Group (CME) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.91% TTM
- Dividend Profile4.24% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History1 split
How this company returns cash to shareholders — buybacks, dividends, and stock splits.